Cart
sales@molnova.com
Olivetol
CAS No. 500-66-3
Olivetol ( —— )
Catalog No. M18664 CAS No. 500-66-3
Olivetol (5-pentylresorcinol, 5-pentyl-1,3-benzenediol) is an organic compound found in certain species of lichen; it is also a precursor in various syntheses of tetrahydrocannabinol. Olivetol has an antioxidant effect.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameOlivetol
-
NoteResearch use only, not for human use.
-
Brief DescriptionOlivetol (5-pentylresorcinol, 5-pentyl-1,3-benzenediol) is an organic compound found in certain species of lichen; it is also a precursor in various syntheses of tetrahydrocannabinol. Olivetol has an antioxidant effect.
-
DescriptionOlivetol (5-pentylresorcinol, 5-pentyl-1,3-benzenediol) is an organic compound found in certain species of lichen; it is also a precursor in various syntheses of tetrahydrocannabinol. Olivetol has an antioxidant effect.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorIκB
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number500-66-3
-
Formula Weight180.24
-
Molecular FormulaC11H16O2
-
Purity98%
-
Solubility——
-
SMILESCCCCCc1cc(cc(c1)O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sarah K. Oettl, et al. PLoS One. 2013; 8(10): e76929.
molnova catalog
related products
-
Schisanhenol
Schisanhenol has antioxidative effect on human LDL oxidation, may be through scavenging free radicals. Schisanhenol has anti-apoptosis effect on BACSs, may be related to its inhibition of ROS generation.
-
(Rac)-5-Keto Fluvast...
(Rac)-5-Keto Fluvastatin is an impurity of Fluvastatin. Fluvastatin is an inhibitor of HMG-CoA reductase(IC50 of 8 nM).
-
VK-II-86
VK-II-86 is a non-β-blocking carvedilol analog. It prevents ouabain-Induced cardiotoxicity.
